Campaign, which traditionally occurs simultaneously throughout the country, began in the north due to seasonal differences in the circulation of the virus
The influenza vaccination campaign, which began on April 7, still faces challenges to reach its goal of immunizing 90% of the target population. To date, only 40% of this goal has been reached, with almost 40 million doses applied. States such as Rio de Janeiro, Bahia, Mato Grosso, Pernambuco, Maranhão and Goiás have below -expected vaccination rates, which concerns the health authorities. Approximately 13.9 million doses were applied to elderly, 4 million in children and 461,500 in pregnant women. The campaign, which traditionally occurs simultaneously across the country, began in the north due to seasonal differences in the circulation of the virus. With the arrival of winter and increased clusters in closed places, health authorities reinforce the importance of vaccination to prevent influenza virus spread.
In addition to the flu, Brazil is also preparing to face another public health challenge: dengue. Minister Alexandre Padilha announced that the expectation is that the dengue vaccine, produced by the Butantã Institute, will be available from next year. Currently, the vaccine is in the evaluation phase by Anvisa, which is analyzing data provided by the Butantã Institute. The government expects to complete all validation processes by the end of 2025, ensuring the security of the immunizer. After ANVISA’s approval, the vaccine should be incorporated into the Unified Health System (SUS) in 2026, allowing the population to begin to immunize themselves against dengue.
